Universal Health Services, Inc. Class B (UHS) Valuation
Historical valuation analysis based on 1280 data points (2021-09-13 to 2026-10-16)
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 in...
Universal Health Services, Inc. Class B (UHS) currently trades at a P/E ratio of 7.15 (historical range: 5.67–24.38, median: 11.02), placing it at the 9th percentile — cheap relative to its history, P/S ratio of 0.60 (range: 0.48–1.23, 13th percentile — cheap relative to its history), EV/EBITDA of 7.79 (range: 6.14–20.69, 11th percentile).
Universal Health Services, Inc. Class B trades well below its historical valuation range across most metrics.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 7.15 | 11.02 | 9th | cheap relative to its history |
| P/S Ratio | 0.60 | 0.77 | 13th | cheap relative to its history |
| EV/EBITDA | 7.79 | 10.97 | 11th | cheap relative to its history |
| FCF Yield | 7.75% | 4.96% | 74th | below its historical average |
Universal Health Services, Inc. Class B (UHS) Valuation & P/E History
Universal Health Services, Inc. Class B (UHS) is a US-listed stock operating in the Healthcare sector, specifically the Medical Care Facilities industry currently trading at $181.40 with a market capitalization of $10.7 billion. This page provides historical valuation analysis for UHS based on 1280 data points covering 2021-09-13 to 2026-10-16. The P/E ratio of 7.15 is below the historical median of 11.02, placing UHS at the 9th percentile of its valuation range. The P/S ratio of 0.60 compares to a median of 0.77.
UHS Valuation Metrics & Historical Range
The valuation table above shows Universal Health Services, Inc. Class B's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether UHS is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests UHS is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Universal Health Services, Inc. Class B.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is UHS Overvalued or Undervalued?
Universal Health Services, Inc. Class B trades well below its historical valuation range across most metrics. The overall valuation percentile of 11 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive UHS is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full UHS analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.UHS trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.